Maryland Capital Management’s Elevance Health ELV Stock Holding History

Maryland Capital Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$4.71M	Buy	+10,361	New	+$4.96M	0.39%	64

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Maryland Capital Management's ELV Position: Q3 2022 in Review

Maryland Capital Management opened a new position in Elevance Health (ELV) in Q3 2022: 10,361 shares worth $4.71M. The stake represents 0.39% of the portfolio and ranks #64 among its holdings.

1,446 funds tracked by Wall St. Rank hold ELV as of Q3 2022.

Maryland Capital Management held 10,361 shares of Elevance Health worth $4.71M as of Q3 2022.
Elevance Health was a new Maryland Capital Management position in Q3 2022.
Elevance Health made up 0.39% of Maryland Capital Management's portfolio in Q3 2022, its #64 holding.
1,446 funds tracked by Wall St. Rank held Elevance Health as of Q3 2022.

Based on Maryland Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.